Symbols / SCLX
SCLX Chart
About
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is based in Palo Alto, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Gen | Market Cap | 59.29M |
| Enterprise Value | 112.96M | Income | -375.84M | Sales | 40.36M |
| Book/sh | -29.75 | Cash/sh | 0.15 | Dividend Yield | — |
| Payout | 0.00% | Employees | 30 | IPO | — |
| P/E | — | Forward P/E | 2.71 | PEG | — |
| P/S | 1.47 | P/B | -0.28 | P/C | — |
| EV/EBITDA | -0.44 | EV/Sales | 2.80 | Quick Ratio | 0.04 |
| Current Ratio | 0.05 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -40.46 | EPS next Y | 3.11 | EPS Growth | — |
| Revenue Growth | -26.90% | Earnings | 2026-03-12 | ROA | -87.43% |
| ROE | — | ROIC | — | Gross Margin | 68.59% |
| Oper. Margin | -17.66% | Profit Margin | 0.00% | Shs Outstand | 7.03M |
| Shs Float | 3.69M | Short Float | 3.33% | Short Ratio | 2.24 |
| Short Interest | — | 52W High | 34.27 | 52W Low | 3.60 |
| Beta | 1.37 | Avg Volume | 75.51K | Volume | 8.44K |
| Target Price | — | Recom | None | Prev Close | $8.23 |
| Price | $8.43 | Change | 2.43% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$8.43
Latest analyst target
3. DCF / Fair value
$-51.33
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$8.43
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-04-11 | down | D. Boral Capital | Buy → Hold | — |
| 2025-04-02 | main | D. Boral Capital | Buy → Buy | $18 |
| 2025-02-28 | main | D. Boral Capital | Buy → Buy | $22 |
| 2025-01-27 | init | D. Boral Capital | — → Buy | $22 |
| 2024-10-21 | reit | HC Wainwright & Co. | Buy → Buy | $7 |
| 2024-10-16 | init | Alliance Global Partners | — → Buy | $14 |
| 2024-06-17 | reit | HC Wainwright & Co. | Buy → Buy | $7 |
| 2024-06-13 | init | Rodman & Renshaw | — → Buy | $13 |
| 2024-06-11 | reit | HC Wainwright & Co. | Buy → Buy | $7 |
| 2024-05-23 | main | HC Wainwright & Co. | Buy → Buy | $7 |
| 2024-05-03 | main | HC Wainwright & Co. | Buy → Buy | $8 |
| 2023-12-04 | reit | HC Wainwright & Co. | Buy → Buy | $12 |
| 2023-10-13 | init | B. Riley Securities | — → Buy | $4 |
| 2023-10-09 | init | HC Wainwright & Co. | — → Buy | $12 |
- Not Many Are Piling Into Scilex Holding Company (NASDAQ:SCLX) Stock Yet As It Plummets 26% - simplywall.st Sat, 10 Jan 2026 08
- Scilex Holding Company's (NASDAQ:SCLX) top owners are retail investors with 57% stake, while 24% is held by private companies - Yahoo Finance Mon, 08 Dec 2025 08
- Trading Systems Reacting to (SCLX) Volatility - Stock Traders Daily Sat, 21 Feb 2026 15
- $SCLX stock is up 11% today. Here's what we see in our data. - Quiver Quantitative Mon, 02 Feb 2026 08
- Scilex Grants Oramed New Warrant in Financing Agreement - The Globe and Mail Sat, 21 Feb 2026 08
- Scilex rises after deal to exchange $200M Semnur stock for Bitcoin - Seeking Alpha ue, 23 Sep 2025 07
- Scilex (SCLX) to Release Quarterly Earnings on Friday - MarketBeat Wed, 18 Feb 2026 13
- $200M Bitcoin Deal: Biotech Scilex Trades Semnur Pharma Shares in Groundbreaking Crypto Exchange - Stock Titan hu, 25 Sep 2025 07
- Can Scilex Stock Recover If Markets Fall? - Trefis Sat, 20 Dec 2025 08
- Datavault AI Announces Closing of Initial Tranche Investment from Scilex Holding Company - Datavault AI Fri, 26 Sep 2025 07
- Retail investors invested in Scilex Holding Company (NASDAQ:SCLX) copped the brunt of last week's US$12m market cap decline - simplywall.st Wed, 17 Dec 2025 08
- Scilex Holding Company (NASDAQ:SCLX) Is Expected To Breakeven In The Near Future - Yahoo Finance ue, 28 Oct 2025 07
- Scilex Holding Company Receives Approval for Dream Bowl 2026 Meme Coin Distribution to Stockholders - Quiver Quantitative ue, 11 Nov 2025 08
- Understanding Momentum Shifts in (SCLX) - Stock Traders Daily Wed, 17 Dec 2025 08
- Scilex (NASDAQ:SCLX) Trading 0.6% Higher - What's Next? - MarketBeat Sat, 14 Feb 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 20657300 | 270814177 | — | Sale at price 12.30 - 14.10 per share. | SCILEX HOLDING CO | Beneficial Owner of more than 10% of a Class of Security | — | 2025-12-30 00:00:00 | D |
| 1 | 30000 | 13800 | — | Purchase at price 0.46 per share. | SHAH JAISIM | Chief Executive Officer | — | 2024-12-18 00:00:00 | D |
| 2 | 8888 | 8351 | — | Purchase at price 0.94 per share. | JI HENRY H | Officer and Director | — | 2024-10-31 00:00:00 | D |
| 3 | 32000 | 31670 | — | Purchase at price 0.99 per share. | SHAH JAISIM | Chief Executive Officer | — | 2024-10-29 00:00:00 | D |
| 4 | 1000 | 990 | — | Purchase at price 0.99 per share. | FOLLOWWILL DORMAN | Director | — | 2024-10-18 00:00:00 | D |
| 5 | 5000 | 4750 | — | Purchase at price 0.95 per share. | CHUN JAY | Director | — | 2024-10-18 00:00:00 | D |
| 6 | 10000 | 9710 | — | Purchase at price 0.97 per share. | JI HENRY H | Officer and Director | — | 2024-10-17 00:00:00 | I |
| 7 | 20000 | 18992 | — | Purchase at price 0.95 per share. | WU YUE ALEXANDER | Director | — | 2024-10-17 00:00:00 | D |
| 8 | 2000 | 1800 | — | Purchase at price 0.90 per share. | LEMUS DAVID | Director | — | 2024-10-17 00:00:00 | D |
| 9 | 30000 | 29751 | — | Purchase at price 0.99 per share. | SHAH JAISIM | Chief Executive Officer | — | 2024-10-16 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 367.05 | -132.30K | 7.74M | -3.46M |
| TaxRateForCalcs | 0.00 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -93.52M | -108.47M | -46.67M | -32.06M |
| TotalUnusualItems | 26.72M | -630.00K | 36.88M | -12.82M |
| TotalUnusualItemsExcludingGoodwill | 26.72M | -630.00K | 36.88M | -12.82M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -72.81M | -114.33M | -23.36M | -88.42M |
| ReconciledDepreciation | 4.05M | 4.15M | 3.96M | 3.78M |
| ReconciledCostOfRevenue | 16.67M | 15.64M | 10.76M | 3.59M |
| EBITDA | -66.80M | -109.10M | -9.79M | -44.88M |
| EBIT | -70.84M | -113.25M | -13.76M | -48.66M |
| NetInterestIncome | -1.96M | -1.07M | -9.60M | -39.76M |
| InterestExpense | 1.96M | 1.07M | 9.60M | 39.76M |
| InterestIncome | 0.00 | |||
| NormalizedIncome | -99.53M | -113.83M | -52.50M | -79.07M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -72.81M | -114.33M | -23.36M | -88.42M |
| TotalExpenses | 149.38M | 152.17M | 88.67M | 67.16M |
| TotalOperatingIncomeAsReported | -83.40M | -105.43M | -50.63M | -35.84M |
| DilutedAverageShares | 3.83M | 3.72M | 3.84M | 3.80M |
| BasicAverageShares | 3.75M | 3.72M | 3.84M | 3.80M |
| DilutedEPS | -21.35 | -44.80 | -5.95 | -23.26 |
| BasicEPS | -19.60 | -44.80 | -5.95 | -23.26 |
| DilutedNIAvailtoComStockholders | -72.81M | -166.98M | -23.36M | -88.42M |
| NetIncomeCommonStockholders | -72.81M | -166.98M | -23.36M | -88.42M |
| OtherunderPreferredStockDividend | 0.00 | 0.00 | ||
| PreferredStockDividends | 52.65M | |||
| NetIncome | -72.81M | -114.33M | -23.36M | -88.42M |
| NetIncomeIncludingNoncontrollingInterests | -72.81M | -114.33M | -23.36M | -88.42M |
| NetIncomeContinuousOperations | -72.81M | -114.33M | -23.36M | -88.42M |
| TaxProvision | -1.00K | 13.00K | 4.00K | 5.00K |
| PretaxIncome | -72.81M | -114.32M | -23.36M | -88.42M |
| OtherIncomeExpense | 21.94M | -7.82M | 36.88M | -12.82M |
| OtherNonOperatingIncomeExpenses | -4.78M | -7.19M | ||
| SpecialIncomeCharges | 9.39M | 0.00 | 28.63M | -12.46M |
| OtherSpecialCharges | -9.39M | -28.63M | 12.46M | |
| GainOnSaleOfSecurity | 17.33M | -630.00K | 8.24M | -354.00K |
| NetNonOperatingInterestIncomeExpense | -1.96M | -1.07M | -9.60M | -39.76M |
| InterestExpenseNonOperating | 1.96M | 1.07M | 9.60M | 39.76M |
| InterestIncomeNonOperating | 0.00 | |||
| OperatingIncome | -92.79M | -105.43M | -50.63M | -35.84M |
| OperatingExpense | 132.69M | 136.49M | 77.87M | 63.52M |
| DepreciationAmortizationDepletionIncomeStatement | 4.03M | 4.11M | 3.92M | 3.74M |
| DepreciationAndAmortizationInIncomeStatement | 4.03M | 4.11M | 3.92M | 3.74M |
| Amortization | 4.03M | 4.11M | 3.92M | 3.74M |
| AmortizationOfIntangiblesIncomeStatement | 4.03M | 4.11M | 3.92M | 3.74M |
| ResearchAndDevelopment | 9.64M | 12.75M | 9.05M | 9.20M |
| SellingGeneralAndAdministration | 119.02M | 119.64M | 64.89M | 50.58M |
| GrossProfit | 39.90M | 31.06M | 27.24M | 27.68M |
| CostOfRevenue | 16.69M | 15.68M | 10.80M | 3.63M |
| TotalRevenue | 56.59M | 46.74M | 38.03M | 31.32M |
| OperatingRevenue | 56.59M | 46.74M | 38.03M | 31.32M |
| Line Item | 2024-12-31 | 2023-12-31 | ||
|---|---|---|---|---|
| TreasurySharesNumber | 1.72M | 1.72M | ||
| OrdinarySharesNumber | 5.24M | 2.86M | 4.04M | 4.03M |
| ShareIssued | 6.95M | 4.57M | 4.04M | 4.03M |
| NetDebt | 32.45M | 121.55M | 148.76M | |
| TotalDebt | 37.96M | 128.46M | 1.41M | 154.75M |
| TangibleBookValue | -238.58M | -222.90M | -17.84M | -276.16M |
| InvestedCapital | -156.92M | -47.47M | 36.24M | -70.78M |
| WorkingCapital | -218.09M | -203.60M | -15.23M | -146.42M |
| NetTangibleAssets | -238.57M | -222.90M | -17.83M | -276.16M |
| CapitalLeaseObligations | 2.24M | 3.00M | 1.41M | 1.65M |
| CommonStockEquity | -192.64M | -172.94M | 36.24M | -223.88M |
| PreferredStockEquity | 1.00K | 3.00K | ||
| TotalCapitalization | -191.80M | -155.90M | 36.24M | -128.34M |
| TotalEquityGrossMinorityInterest | -192.64M | -172.94M | 36.24M | -223.88M |
| StockholdersEquity | -192.64M | -172.94M | 36.24M | -223.88M |
| GainsLossesNotAffectingRetainedEarnings | 6.32M | 0.00 | ||
| OtherEquityAdjustments | 6.32M | |||
| TreasuryStock | 90.52M | 90.52M | 0.00 | |
| RetainedEarnings | -563.05M | -490.25M | -375.91M | -352.55M |
| AdditionalPaidInCapital | 454.59M | 407.81M | 412.14M | 128.66M |
| CapitalStock | 25.00K | 16.00K | 17.00K | 13.00K |
| CommonStock | 24.00K | 16.00K | 14.00K | 13.00K |
| PreferredStock | 1.00K | 0.00 | 3.00K | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 285.59M | 274.25M | 50.29M | 301.81M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 25.96M | 23.87M | 5.45M | 132.39M |
| OtherNonCurrentLiabilities | 155.00K | 179.00K | 163.00K | |
| DerivativeProductLiabilities | 18.30M | 1.52M | 1.23M | 35.70M |
| NonCurrentDeferredLiabilities | 5.13M | 2.90M | 3.39M | 0.00 |
| NonCurrentDeferredRevenue | 2.69M | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 2.37M | 19.27M | 665.00K | 96.69M |
| LongTermCapitalLeaseObligation | 1.52M | 2.24M | 665.00K | 1.15M |
| LongTermDebt | 845.00K | 17.04M | 95.54M | |
| CurrentLiabilities | 259.63M | 250.38M | 44.84M | 169.42M |
| CurrentDeferredLiabilities | 4.56M | 491.00K | 264.00K | 0.00 |
| CurrentDeferredRevenue | 4.12M | 0.00 | ||
| CurrentDebtAndCapitalLeaseObligation | 35.59M | 109.19M | 745.00K | 58.06M |
| CurrentCapitalLeaseObligation | 714.00K | 759.00K | 745.00K | 500.00K |
| CurrentDebt | 34.88M | 108.43M | 57.56M | |
| OtherCurrentBorrowings | 34.88M | 108.43M | 57.56M | |
| PayablesAndAccruedExpenses | 219.48M | 140.70M | 43.83M | 111.36M |
| CurrentAccruedExpenses | 165.99M | 98.30M | 35.38M | 14.35M |
| Payables | 53.50M | 42.41M | 8.45M | 97.01M |
| DuetoRelatedPartiesCurrent | 0.00 | 92.72M | ||
| TotalTaxPayable | 876.00K | 1.45M | 0.00 | |
| AccountsPayable | 52.62M | 40.95M | 8.45M | 4.28M |
| TotalAssets | 92.95M | 101.31M | 86.53M | 77.93M |
| TotalNonCurrentAssets | 51.41M | 54.53M | 56.92M | 54.93M |
| OtherNonCurrentAssets | 119.00K | 897.00K | 944.00K | 538.00K |
| NonCurrentPrepaidAssets | 538.00K | |||
| InvestmentsAndAdvances | 2.42M | 0.00 | ||
| GoodwillAndOtherIntangibleAssets | 45.93M | 49.97M | 54.07M | 52.28M |
| OtherIntangibleAssets | 32.45M | 36.48M | 40.59M | 38.80M |
| Goodwill | 13.48M | 13.48M | 13.48M | 13.48M |
| NetPPE | 2.93M | 3.67M | 1.90M | 2.11M |
| AccumulatedDepreciation | -64.00K | -58.00K | -167.00K | -127.00K |
| GrossPPE | 3.00M | 3.72M | 2.07M | 2.23M |
| Leases | 50.00K | 50.00K | 55.00K | 48.00K |
| ConstructionInProgress | 689.00K | 689.00K | 689.00K | 689.00K |
| OtherProperties | 2.23M | 2.94M | 1.13M | 1.30M |
| MachineryFurnitureEquipment | 33.00K | 41.00K | 195.00K | 195.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 41.55M | 46.78M | 29.61M | 23.00M |
| OtherCurrentAssets | 9.40M | 4.05M | 4.81M | 1.83M |
| PrepaidAssets | 1.83M | |||
| Inventory | 2.44M | 4.21M | 1.38M | 2.56M |
| Receivables | 26.44M | 34.60M | 21.24M | 14.27M |
| AccountsReceivable | 26.44M | 34.60M | 21.24M | 14.27M |
| CashCashEquivalentsAndShortTermInvestments | 3.27M | 3.92M | 2.18M | 4.34M |
| CashAndCashEquivalents | 3.27M | 3.92M | 2.18M | 4.34M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 18.75M | -21.04M | -23.32M | -28.66M |
| RepurchaseOfCapitalStock | 0.00 | -10.00M | 0.00 | 0.00 |
| RepaymentOfDebt | -184.65M | -109.63M | -103.61M | -82.22M |
| IssuanceOfDebt | 120.44M | 110.35M | 72.36M | 62.53M |
| IssuanceOfCapitalStock | 44.64M | 35.46M | 0.00 | 0.00 |
| CapitalExpenditure | -600.00K | -330.00K | -2.07M | |
| InterestPaidSupplementalData | 1.56M | 1.43M | 0.00 | 0.00 |
| EndCashPosition | 3.27M | 4.73M | 2.18M | 4.34M |
| BeginningCashPosition | 4.73M | 2.18M | 4.34M | 4.84M |
| ChangesInCash | -1.46M | 2.54M | -2.15M | -501.00K |
| FinancingCashFlow | -18.13M | 23.58M | 21.17M | 28.16M |
| CashFlowFromContinuingFinancingActivities | -18.13M | 23.58M | 21.17M | 28.16M |
| NetOtherFinancingCharges | -371.00K | -3.74M | 52.33M | 47.85M |
| ProceedsFromStockOptionExercised | 1.81M | 1.14M | 96.00K | 0.00 |
| NetCommonStockIssuance | 44.64M | 25.46M | 0.00 | 0.00 |
| CommonStockPayments | 0.00 | -10.00M | 0.00 | 0.00 |
| CommonStockIssuance | 44.64M | 35.46M | 0.00 | 0.00 |
| NetIssuancePaymentsOfDebt | -64.21M | 728.00K | -31.25M | -19.69M |
| NetShortTermDebtIssuance | 24.00M | 0.00 | 0.00 | |
| ShortTermDebtPayments | -84.63M | 0.00 | 0.00 | |
| ShortTermDebtIssuance | 24.00M | 0.00 | 0.00 | |
| NetLongTermDebtIssuance | -64.21M | 728.00K | -31.25M | -19.69M |
| LongTermDebtPayments | -184.65M | -109.63M | -103.61M | -82.22M |
| LongTermDebtIssuance | 120.44M | 110.35M | 72.36M | 62.53M |
| InvestingCashFlow | -2.67M | -330.00K | -2.07M | 0.00 |
| CashFlowFromContinuingInvestingActivities | -2.67M | -330.00K | -2.07M | 0.00 |
| NetInvestmentPurchaseAndSale | -2.08M | 0.00 | ||
| PurchaseOfInvestment | -2.08M | 0.00 | ||
| NetBusinessPurchaseAndSale | 0.00 | |||
| PurchaseOfBusiness | 0.00 | |||
| NetIntangiblesPurchaseAndSale | -600.00K | -300.00K | -2.06M | 0.00 |
| PurchaseOfIntangibles | -600.00K | -300.00K | -2.06M | 0.00 |
| NetPPEPurchaseAndSale | 0.00 | -30.00K | -7.00K | 0.00 |
| PurchaseOfPPE | 0.00 | -30.00K | -7.00K | 0.00 |
| OperatingCashFlow | 19.35M | -20.71M | -21.26M | -28.66M |
| CashFlowFromContinuingOperatingActivities | 19.35M | -20.71M | -21.26M | -28.66M |
| ChangeInWorkingCapital | 64.84M | 65.80M | 45.67M | 13.60M |
| ChangeInOtherCurrentLiabilities | -782.00K | -695.00K | -229.00K | -80.00K |
| ChangeInOtherCurrentAssets | -30.00K | 855.00K | 350.00K | 0.00 |
| ChangeInPayablesAndAccruedExpense | 70.94M | 82.28M | 53.96M | 14.76M |
| ChangeInAccruedExpense | 63.52M | 62.40M | 21.03M | 388.00K |
| ChangeInPayable | 7.42M | 19.88M | 32.93M | 14.37M |
| ChangeInAccountPayable | 7.42M | 19.88M | 2.81M | -3.84M |
| ChangeInPrepaidAssets | -479.00K | -441.00K | -2.63M | 1.48M |
| ChangeInInventory | 1.46M | -2.84M | 1.18M | -1.42M |
| ChangeInReceivables | -6.27M | -13.36M | -6.97M | -1.14M |
| ChangesInAccountReceivables | -6.27M | -13.36M | -6.97M | -1.14M |
| OtherNonCashItems | 6.48M | 8.57M | -17.56M | 23.79M |
| StockBasedCompensation | 15.69M | 14.60M | 5.28M | 5.82M |
| ProvisionandWriteOffofAssets | 18.48M | 0.00 | ||
| DepreciationAmortizationDepletion | 4.05M | 4.15M | 3.96M | 3.78M |
| DepreciationAndAmortization | 4.05M | 4.15M | 3.96M | 3.78M |
| OperatingGainsLosses | -17.38M | 512.00K | -35.25M | 12.76M |
| GainLossOnInvestmentSecurities | -17.38M | 512.00K | -6.61M | 300.00K |
| NetIncomeFromContinuingOperations | -72.81M | -114.33M | -23.36M | -88.42M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for SCLX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|